Suspected immune mediated response to COVID-19 vaccine: two individual case reports

Authors

  • Sagar R. Bhimani Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
  • Sapna D. Gupta Department of Emergency Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
  • Kamlesh P. Patel Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
  • Supriya D. Malhotra Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20212385

Keywords:

COVID 19 vaccine, Adverse event, Pancreatitis, Typhilitis, AEFI

Abstract

SARS-CoV-2, the virus that causes coronavirus disease 19 (COVID-19), has spread rapidly around the world. Researchers have been working round the clock to develop effective vaccines, which people started receiving in December 2020. Therefore, careful follow-up and surveillance studies for continued vaccine safety monitoring will be needed to ascertain the potential risks of such adverse events or disease. Here, we present two individual cases of pancreatitis and typhilitis following COVID 19 vaccination. In the first case of a 38 years old male patient developed pancreatitis after 4 days of COVID 19 vaccination and in second case, of a 60 years old female patient developing typhilitis after just one day after vaccination. All possible causes of this occurrence were ruled out. Two main factors suggest a possible link to the vaccine, the chronology of the events and the incongruent immune response to the vaccine component. It is not possible to establish a direct causal relation between vaccination and adverse event following immunization; however, this report can be used to alert practitioners to this possibility of adverse event following immunization after COVID-19 vaccine.

Metrics

Metrics Loading ...

Author Biographies

Sagar R. Bhimani, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India

Department of Pharmacology,1st year Resident Doctor

Sapna D. Gupta, Department of Emergency Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India

Department of Emergency Medicine,Associate Professor

Kamlesh P. Patel, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India

Department of Pharmacology,Associate Professor

Supriya D. Malhotra, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India

Department of Pharmacology,Professor and Head of Department

References

WHO director-general’s opening remarks at the media briefing on COVID-19. Abailable at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re. Accessed on 7 Septe-mber 2020.

Haynes BF, Corey L, Fernandes P, Gilbert PB, Hotez PJ, Rao S, et al. Prospects for a safe COVID-19 vaccine. Sci Transl Med. 2020;12(568):445-9.

Sarles H, Sarles JC, Muratore R. Chronic inflammatory sclerosis of the pancreas-An autonomous pancreatic disease?. Am J Dig Dis. 1961;6:688-98.

Sahel J, Barthet M, Gasmi M. Autoimmune pancreatitis: increasing evidence for a clinical entity with various patterns. Eur J Gastroenterol Hepato.l 2004;16:1265-8.

Shlomovitz E, Davies W, Cairns E, Brintnell WC, Goldszmidt M, Dresser GK. Severe necrotizing pancreatitis following combined hepatitis A and B vaccination. CMAJ. 2007;176(3):339-42.

Janigan DT, Nevalainen TJ, MacAulay MA. Foreign serum-induced pancreatitis in mice. I. A new model of acute pancreatitis. Lab Invest. 1975;33:591-607.

Urbach DR, Rotstein OD, Typhlitis. Canadian journal of surgery. J Canad de Chirurgie. 1999; 42(6):415-9.

Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, et al. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol. Rep. 2020;7:1448-58.

Downloads

Published

2021-06-22

How to Cite

Bhimani, S. R., Gupta, S. D., Patel, K. P., & Malhotra, S. D. (2021). Suspected immune mediated response to COVID-19 vaccine: two individual case reports. International Journal of Basic & Clinical Pharmacology, 10(7), 851–854. https://doi.org/10.18203/2319-2003.ijbcp20212385

Issue

Section

Case Reports